Predicting pathological complete response to breast cancer neoadjuvant therapy using multi-combination machine learning models based on vision transformer features
Open Access
- 31 December 2025
- journal article
- research article
- Published by Springer Nature in Scientific Reports
- Vol. 16 (1)
Abstract
The significance of multi-combination machine learning models utilizing vision transformer (VIT) features in forecasting pathological complete response (pCR) after breast cancer neoadjuvant therapy (NAT). A retrospective study was conducted on 124 breast cancer patients who were confirmed by biopsy pathology and underwent surgical resection after NAT to evaluate pCR, and they were divided into a training cohort (n = 87) and a validation cohort (n = 37). Deep learning features were extracted from pre-biopsy ultrasound images based on VIT, ResNet50, and VGG16 convolutional neural network algorithms. Based on the Wilcoxon test, 9, 7, and 7 high-value features were identified from VIT, Resnet50, and VGG16 features, respectively. Using 12 machine learning algorithms, 111, 87, and 82 models were developed utilizing VIT, Resnet50, and VGG16 features. The Stepglm [forward], NaiveBayes, and glmBoost + Ridge ensemble algorithms achieved the highest area under the curve (AUCs). In both the training and validation cohorts, the AUCs of the optimal algorithms were: 0.872 and 0.839 for VIT, 0.837 and 0.804 for Resnet50, and 0.835 and 0.804 for VGG16. The predictive models developed based on VIT features have higher values in evaluating NAT-pCR for breast cancer compared to features quantified by other deep learning algorithms. The application of multi-combination models allows for the selection of the optimal algorithm to achieve higher prediction performance.Keywords
Funding Information
- Science and Technology Planning Project of Maoming City (2024109)
This publication has 47 references indexed in Scilit:
- Ultrasound-based radiomics for early predicting response to neoadjuvant chemotherapy in patients with breast cancer: a systematic review with meta-analysisLa radiologia medica, 2024
- Ultrasound‐based radiomics‐clinical nomogram for noninvasive prediction of residual cancer burden grading in breast cancerJournal of Clinical Ultrasound, 2024
- The predictive value of systemic immune-inflammatory markers before and after treatment for pathological complete response in patients undergoing neoadjuvant therapy for breast cancer: a retrospective study of 1994 patientsClinical and Translational Oncology, 2024
- Ultrasound and clinicopathological characteristics-based model for prediction of pathologic response to neoadjuvant chemotherapy in HER2-positive breast cancer: a case–control studyBreast Cancer Research and Treatment, 2023
- A hierarchical self‐attention‐guided deep learning framework to predict breast cancer response to chemotherapy using pre‑treatment tumor biopsiesMedical Physics, 2023
- Deep Learning Model Based on Dual-Modal Ultrasound and Molecular Data for Predicting Response to Neoadjuvant Chemotherapy in Breast CancerAcademic Radiology, 2023
- Pretreatment ultrasound-based deep learning radiomics model for the early prediction of pathologic response to neoadjuvant chemotherapy in breast cancerEuropean Radiology, 2023
- Early prediction of treatment response to neoadjuvant chemotherapy based on longitudinal ultrasound images of HER2-positive breast cancer patients by Siamese multi-task network: A multicentre, retrospective cohort studyeClinicalMedicine, 2022
- Prediction of the Pathological Response to Neoadjuvant Chemotherapy in Breast Cancer Patients With MRI-Radiomics: A Systematic Review and Meta-analysisCurrent Problems in Cancer, 2022
- Tumor‐stroma ratio is associated with Miller‐Payne score and pathological response to neoadjuvant chemotherapy in HER2‐negative early breast cancerInternational Journal of Cancer, 2021